VEGF Trap-Eye in Choroidal Neovascularization Secondary to Pathologic Myopia (mCNV)

Clinical trial NCT01249664 · COMPLETED

Trial details

NCT number: NCT01249664
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Myopia, Pathological

Start date: 2010-12-01
Primary completion: 2013-02-01
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.